Immediate Impact
59 standout
Citing Papers
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
2023 Standout
Works of Robert Niecestro being referenced
Abstract 2078: CK-101 (RX518), a mutant-selective inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC
2017
Phase II study of single agent perifosine in patients with hepatocellular carcinoma (HCC)
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert Niecestro | 80 | 43 | 107 | 81 | 29 | 325 | |
| J. Mulder | 80 | 51 | 32 | 28 | 20 | 371 | |
| Yuki Narita | 50 | 92 | 105 | 19 | 33 | 322 | |
| Yiming Wang | 30 | 133 | 136 | 46 | 24 | 352 | |
| Elisabeth C. Samouilidou | 85 | 40 | 98 | 27 | 26 | 359 | |
| Andrzej Oko | 52 | 67 | 102 | 22 | 46 | 307 | |
| Christine Ahlström | 72 | 116 | 65 | 7 | 23 | 367 | |
| Lisandro Pereyra | 121 | 27 | 19 | 40 | 32 | 364 | |
| Christel Van Campenhout | 34 | 47 | 18 | 79 | 22 | 314 | |
| Ramazan Esen | 49 | 51 | 43 | 44 | 29 | 321 | |
| Zunsong Wang | 56 | 124 | 180 | 19 | 30 | 360 |
All Works
Loading papers...